These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 29288140
21. Cysteine proteases of malaria parasites: targets for chemotherapy. Rosenthal PJ, Sijwali PS, Singh A, Shenai BR. Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997 [Abstract] [Full Text] [Related]
23. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. Dahl EL, Rosenthal PJ. Mol Biochem Parasitol; 2005 Feb; 139(2):205-12. PubMed ID: 15664655 [Abstract] [Full Text] [Related]
24. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Shenai BR, Lee BJ, Alvarez-Hernandez A, Chong PY, Emal CD, Neitz RJ, Roush WR, Rosenthal PJ. Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184 [Abstract] [Full Text] [Related]
25. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132. Prasad R, Atul, Kolla VK, Legac J, Singhal N, Navale R, Rosenthal PJ, Sijwali PS. PLoS One; 2013 Jan; 8(9):e73530. PubMed ID: 24023882 [Abstract] [Full Text] [Related]
26. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series. Coterón JM, Catterick D, Castro J, Chaparro MJ, Díaz B, Fernández E, Ferrer S, Gamo FJ, Gordo M, Gut J, de las Heras L, Legac J, Marco M, Miguel J, Muñoz V, Porras E, de la Rosa JC, Ruiz JR, Sandoval E, Ventosa P, Rosenthal PJ, Fiandor JM. J Med Chem; 2010 Aug 26; 53(16):6129-52. PubMed ID: 20672841 [Abstract] [Full Text] [Related]
27. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors. Mane UR, Li H, Huang J, Gupta RC, Nadkarni SS, Giridhar R, Naik PP, Yadav MR. Bioorg Med Chem; 2012 Nov 01; 20(21):6296-304. PubMed ID: 23040894 [Abstract] [Full Text] [Related]
28. Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid. Dude MA, Kaeppler U, Herb M, Schiller M, Schulz F, Vedder B, Heppner S, Pradel G, Gut J, Rosenthal PJ, Schirmeister T, Leippe M, Gelhaus C. Molecules; 2008 Dec 23; 14(1):19-35. PubMed ID: 19104483 [Abstract] [Full Text] [Related]
29. Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum. Bertoldo JB, Chiaradia-Delatorre LD, Mascarello A, Leal PC, Cordeiro MN, Nunes RJ, Sarduy ES, Rosenthal PJ, Terenzi H. J Enzyme Inhib Med Chem; 2015 Apr 23; 30(2):299-307. PubMed ID: 24964346 [Abstract] [Full Text] [Related]
30. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria. Li X, Chen H, Jeong JJ, Chishti AH. Mol Biochem Parasitol; 2007 Sep 23; 155(1):26-32. PubMed ID: 17583361 [Abstract] [Full Text] [Related]
31. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Greenbaum DC, Baruch A, Grainger M, Bozdech Z, Medzihradszky KF, Engel J, DeRisi J, Holder AA, Bogyo M. Science; 2002 Dec 06; 298(5600):2002-6. PubMed ID: 12471262 [Abstract] [Full Text] [Related]
32. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport. Singh A, Rosenthal PJ. J Biol Chem; 2004 Aug 20; 279(34):35236-41. PubMed ID: 15192087 [Abstract] [Full Text] [Related]
33. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II. Jin H, Xu Z, Cui K, Zhang T, Lu W, Huang J. Fitoterapia; 2014 Apr 20; 94():55-61. PubMed ID: 24468190 [Abstract] [Full Text] [Related]
34. Hypervalent organotellurium compounds as inhibitors of P. falciparum calcium-dependent cysteine proteases. El Chamy Maluf S, Melo PMS, Varotti FP, Gazarini ML, Cunha RLOR, Carmona AK. Parasitol Int; 2016 Feb 20; 65(1):20-22. PubMed ID: 26384965 [Abstract] [Full Text] [Related]
35. Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytes. Glushakova S, Mazar J, Hohmann-Marriott MF, Hama E, Zimmerberg J. Cell Microbiol; 2009 Jan 20; 11(1):95-105. PubMed ID: 19016793 [Abstract] [Full Text] [Related]
36. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. Moura PA, Dame JB, Fidock DA. Antimicrob Agents Chemother; 2009 Dec 20; 53(12):4968-78. PubMed ID: 19752273 [Abstract] [Full Text] [Related]
37. Antimalarial synergy of cysteine and aspartic protease inhibitors. Semenov A, Olson JE, Rosenthal PJ. Antimicrob Agents Chemother; 1998 Sep 20; 42(9):2254-8. PubMed ID: 9736544 [Abstract] [Full Text] [Related]
38. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next? González JEH, Salas-Sarduy E, Alvarez LH, Valiente PA, Arni RK, Pascutti PG. Curr Med Chem; 2024 Sep 20; 31(16):2234-2263. PubMed ID: 37711130 [Abstract] [Full Text] [Related]
39. A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression. Dasaradhi PV, Mohmmed A, Kumar A, Hossain MJ, Bhatnagar RK, Chauhan VS, Malhotra P. Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1062-8. PubMed ID: 16165088 [Abstract] [Full Text] [Related]
40. Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials. Praveen Kumar S, Gut J, Guedes RC, Rosenthal PJ, Santos MM, Moreira R. Eur J Med Chem; 2011 Mar 04; 46(3):927-33. PubMed ID: 21295887 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]